10 20 30 40 50 60 70 80 3I3N - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER PROTEIN BINDING 30-JUN-09 3I3N
TITLE CRYSTAL STRUCTURE OF THE BTB-BACK DOMAINS OF HUMAN KLHL11
COMPND MOL_ID: 1; COMPND 2 MOLECULE: KELCH-LIKE PROTEIN 11; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: BTB-BACK DOMAINS (UNP RESIDUES 67-340); COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: KLHL11, KLHL11A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS STRUCTURAL GENOMICS, BTB, KLHL11A, SGC, STRUCTURAL GENOMICS KEYWDS 2 CONSORTIUM, KELCH REPEAT, SECRETED, PROTEIN BINDING
EXPDTA X-RAY DIFFRACTION
AUTHOR J.W.MURRAY,C.D.O.COOPER,T.KROJER,P.MAHAJAN,E.SALAH,T.KEATES, AUTHOR 2 P.SAVITSKY,A.C.W.PIKE,A.ROOS,J.MUNIZ,F.VON DELFT,C.BOUNTRA, AUTHOR 3 C.H.ARROWSMITH,J.WEIGELT,A.EDWARDS,S.KNAPP,A.BULLOCK, AUTHOR 4 STRUCTURAL GENOMICS CONSORTIUM (SGC)
REVDAT 2 22-SEP-09 3I3N 1 AUTHOR JRNL REVDAT 1 04-AUG-09 3I3N 0
JRNL AUTH J.W.MURRAY,C.D.O.COOPER,T.KROJER,P.MAHAJAN,E.SALAH, JRNL AUTH 2 T.KEATES,P.SAVITSKY,A.C.W.PIKE,A.ROOS,J.MUNIZ, JRNL AUTH 3 F.VON DELFT,C.BOUNTRA,C.H.ARROWSMITH,J.WEIGELT, JRNL AUTH 4 A.EDWARDS,S.KNAPP,A.BULLOCK, JRNL AUTH 5 STRUCTURAL GENOMICS CONSORTIUM (SGC) JRNL TITL CRYSTAL STRUCTURE OF THE BTB-BACK DOMAINS OF HUMAN JRNL TITL 2 KLHL11 JRNL REF TO BE PUBLISHED JRNL REFN
REMARK 1
REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.33 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 23387 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.260 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1206 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 97.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3600 REMARK 3 BIN FREE R VALUE : 0.3930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : 93 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.041 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4364 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 6 REMARK 3 SOLVENT ATOMS : 80 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 64.80 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.25 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.40 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.82 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : ISOTROPIC REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 3I3N COMPLIES WITH FORMAT V. 3.20, 01-DEC-08
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 06-JUL-09. REMARK 100 THE RCSB ID CODE IS RCSB053922.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 11-NOV-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X10SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.99590 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23589 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 45.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.6 REMARK 200 DATA REDUNDANCY : 6.200 REMARK 200 R MERGE (I) : 0.11500 REMARK 200 R SYM (I) : 0.11500 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 13.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.74 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 4.70 REMARK 200 R MERGE FOR SHELL (I) : 0.49200 REMARK 200 R SYM FOR SHELL (I) : 0.49200 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 58.01 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.25M K THIOCYANATE, 25W/V PEG REMARK 280 3350, 5V/V ETHYLENE GLYCOL, BIS TRIS PROPANE, PH 7.5, VAPOR REMARK 280 DIFFUSION, SITTING DROP, TEMPERATURE 277K
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 34.43950 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5240 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 28930 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -51.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 101 REMARK 465 GLY A 102 REMARK 465 ALA A 103 REMARK 465 GLY A 104 REMARK 465 SER A 127 REMARK 465 GLY A 128 REMARK 465 GLN A 129 REMARK 465 PHE A 130 REMARK 465 SER A 131 REMARK 465 GLU A 132 REMARK 465 SER A 133 REMARK 465 ARG A 134 REMARK 465 ILE A 336 REMARK 465 GLN A 337 REMARK 465 SER A 338 REMARK 465 GLY A 339 REMARK 465 THR A 340 REMARK 465 TYR B -4 REMARK 465 PHE B -3 REMARK 465 GLN B -2 REMARK 465 GLY B 102 REMARK 465 ALA B 103 REMARK 465 GLY B 104 REMARK 465 ASN B 335 REMARK 465 ILE B 336 REMARK 465 GLN B 337 REMARK 465 SER B 338 REMARK 465 GLY B 339 REMARK 465 THR B 340
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 GLY A 136 N - CA - C ANGL. DEV. = 15.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A -2 6.73 -56.63 REMARK 500 PRO A 124 15.62 -64.78 REMARK 500 TRP A 143 -158.66 -109.90 REMARK 500 LEU A 202 -26.45 -39.27 REMARK 500 THR A 216 70.45 46.28 REMARK 500 LEU A 217 63.13 -115.68 REMARK 500 SER A 218 -58.80 -25.65 REMARK 500 ASN A 277 73.07 -151.67 REMARK 500 GLU A 279 -73.76 -43.11 REMARK 500 PRO B 124 7.44 -60.25 REMARK 500 TRP B 143 -158.73 -112.45 REMARK 500 LEU B 202 -28.97 -39.15 REMARK 500 THR B 216 76.00 42.26 REMARK 500 LEU B 217 65.93 -117.64 REMARK 500 SER B 218 -68.40 -27.63 REMARK 500 ASN B 277 77.59 -150.52 REMARK 500 GLU B 279 -75.90 -41.23 REMARK 500 ALA B 333 6.40 -59.64 REMARK 500 REMARK 500 REMARK: NULL
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SCN A 6788 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 3
DBREF 3I3N A 67 340 UNP Q9NVR0 KLH11_HUMAN 67 340 DBREF 3I3N B 67 340 UNP Q9NVR0 KLH11_HUMAN 67 340
SEQADV 3I3N TYR A -4 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N PHE A -3 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N GLN A -2 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N SER A -1 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N MSE A 0 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N TYR B -4 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N PHE B -3 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N GLN B -2 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N SER B -1 UNP Q9NVR0 EXPRESSION TAG SEQADV 3I3N MSE B 0 UNP Q9NVR0 EXPRESSION TAG
SEQRES 1 A 279 TYR PHE GLN SER MSE GLU ALA GLU ASP PHE GLU CYS SER SEQRES 2 A 279 SER HIS CYS SER GLU LEU SER TRP ARG GLN ASN GLU GLN SEQRES 3 A 279 ARG ARG GLN GLY LEU PHE CYS ASP ILE THR LEU CYS PHE SEQRES 4 A 279 GLY GLY ALA GLY GLY ARG GLU PHE ARG ALA HIS ARG SER SEQRES 5 A 279 VAL LEU ALA ALA ALA THR GLU TYR PHE THR PRO LEU LEU SEQRES 6 A 279 SER GLY GLN PHE SER GLU SER ARG SER GLY ARG VAL GLU SEQRES 7 A 279 MSE ARG LYS TRP SER SER GLU PRO GLY PRO GLU PRO ASP SEQRES 8 A 279 THR VAL GLU ALA VAL ILE GLU TYR MSE TYR THR GLY ARG SEQRES 9 A 279 ILE ARG VAL SER THR GLY SER VAL HIS GLU VAL LEU GLU SEQRES 10 A 279 LEU ALA ASP ARG PHE LEU LEU ILE ARG LEU LYS GLU PHE SEQRES 11 A 279 CYS GLY GLU PHE LEU LYS LYS LYS LEU HIS LEU SER ASN SEQRES 12 A 279 CYS VAL ALA ILE HIS SER LEU ALA HIS MSE TYR THR LEU SEQRES 13 A 279 SER GLN LEU ALA LEU LYS ALA ALA ASP MSE ILE ARG ARG SEQRES 14 A 279 ASN PHE HIS LYS VAL ILE GLN ASP GLU GLU PHE TYR THR SEQRES 15 A 279 LEU PRO PHE HIS LEU ILE ARG ASP TRP LEU SER ASP LEU SEQRES 16 A 279 GLU ILE THR VAL ASP SER GLU GLU VAL LEU PHE GLU THR SEQRES 17 A 279 VAL LEU LYS TRP VAL GLN ARG ASN ALA GLU GLU ARG GLU SEQRES 18 A 279 ARG TYR PHE GLU GLU LEU PHE LYS LEU LEU ARG LEU SER SEQRES 19 A 279 GLN MSE LYS PRO THR TYR LEU THR ARG HIS VAL LYS PRO SEQRES 20 A 279 GLU ARG LEU VAL ALA ASN ASN GLU VAL CYS VAL LYS LEU SEQRES 21 A 279 VAL ALA ASP ALA VAL GLU ARG HIS ALA LEU ARG ALA GLU SEQRES 22 A 279 ASN ILE GLN SER GLY THR SEQRES 1 B 279 TYR PHE GLN SER MSE GLU ALA GLU ASP PHE GLU CYS SER SEQRES 2 B 279 SER HIS CYS SER GLU LEU SER TRP ARG GLN ASN GLU GLN SEQRES 3 B 279 ARG ARG GLN GLY LEU PHE CYS ASP ILE THR LEU CYS PHE SEQRES 4 B 279 GLY GLY ALA GLY GLY ARG GLU PHE ARG ALA HIS ARG SER SEQRES 5 B 279 VAL LEU ALA ALA ALA THR GLU TYR PHE THR PRO LEU LEU SEQRES 6 B 279 SER GLY GLN PHE SER GLU SER ARG SER GLY ARG VAL GLU SEQRES 7 B 279 MSE ARG LYS TRP SER SER GLU PRO GLY PRO GLU PRO ASP SEQRES 8 B 279 THR VAL GLU ALA VAL ILE GLU TYR MSE TYR THR GLY ARG SEQRES 9 B 279 ILE ARG VAL SER THR GLY SER VAL HIS GLU VAL LEU GLU SEQRES 10 B 279 LEU ALA ASP ARG PHE LEU LEU ILE ARG LEU LYS GLU PHE SEQRES 11 B 279 CYS GLY GLU PHE LEU LYS LYS LYS LEU HIS LEU SER ASN SEQRES 12 B 279 CYS VAL ALA ILE HIS SER LEU ALA HIS MSE TYR THR LEU SEQRES 13 B 279 SER GLN LEU ALA LEU LYS ALA ALA ASP MSE ILE ARG ARG SEQRES 14 B 279 ASN PHE HIS LYS VAL ILE GLN ASP GLU GLU PHE TYR THR SEQRES 15 B 279 LEU PRO PHE HIS LEU ILE ARG ASP TRP LEU SER ASP LEU SEQRES 16 B 279 GLU ILE THR VAL ASP SER GLU GLU VAL LEU PHE GLU THR SEQRES 17 B 279 VAL LEU LYS TRP VAL GLN ARG ASN ALA GLU GLU ARG GLU SEQRES 18 B 279 ARG TYR PHE GLU GLU LEU PHE LYS LEU LEU ARG LEU SER SEQRES 19 B 279 GLN MSE LYS PRO THR TYR LEU THR ARG HIS VAL LYS PRO SEQRES 20 B 279 GLU ARG LEU VAL ALA ASN ASN GLU VAL CYS VAL LYS LEU SEQRES 21 B 279 VAL ALA ASP ALA VAL GLU ARG HIS ALA LEU ARG ALA GLU SEQRES 22 B 279 ASN ILE GLN SER GLY THR
MODRES 3I3N MSE A 0 MET SELENOMETHIONINE MODRES 3I3N MSE A 140 MET SELENOMETHIONINE MODRES 3I3N MSE A 161 MET SELENOMETHIONINE MODRES 3I3N MSE A 214 MET SELENOMETHIONINE MODRES 3I3N MSE A 227 MET SELENOMETHIONINE MODRES 3I3N MSE A 297 MET SELENOMETHIONINE MODRES 3I3N MSE B 0 MET SELENOMETHIONINE MODRES 3I3N MSE B 140 MET SELENOMETHIONINE MODRES 3I3N MSE B 161 MET SELENOMETHIONINE MODRES 3I3N MSE B 214 MET SELENOMETHIONINE MODRES 3I3N MSE B 227 MET SELENOMETHIONINE MODRES 3I3N MSE B 297 MET SELENOMETHIONINE
HET MSE A 0 8 HET MSE A 140 8 HET MSE A 161 8 HET MSE A 214 8 HET MSE A 227 8 HET MSE A 297 8 HET MSE B 0 8 HET MSE B 140 8 HET MSE B 161 8 HET MSE B 214 8 HET MSE B 227 8 HET MSE B 297 8 HET SCN A6788 3 HET CL A 2 1 HET CL B 1 1 HET CL B 3 1
HETNAM MSE SELENOMETHIONINE HETNAM SCN THIOCYANATE ION HETNAM CL CHLORIDE ION
FORMUL 1 MSE 12(C5 H11 N O2 SE) FORMUL 3 SCN C N S 1- FORMUL 4 CL 3(CL 1-) FORMUL 7 HOH *80(H2 O)
HELIX 1 1 SER A 75 GLN A 90 1 16 HELIX 2 2 HIS A 111 THR A 119 1 9 HELIX 3 3 PHE A 122 LEU A 126 5 5 HELIX 4 4 GLU A 150 GLY A 164 1 15 HELIX 5 5 SER A 172 PHE A 183 1 12 HELIX 6 6 LEU A 185 LEU A 200 1 16 HELIX 7 7 ASN A 204 TYR A 215 1 12 HELIX 8 8 LEU A 217 ASN A 231 1 15 HELIX 9 9 ASN A 231 ILE A 236 1 6 HELIX 10 10 GLU A 239 LEU A 244 5 6 HELIX 11 11 PRO A 245 SER A 254 1 10 HELIX 12 12 SER A 262 ARG A 276 1 15 HELIX 13 13 ASN A 277 GLU A 282 1 6 HELIX 14 14 TYR A 284 LYS A 290 1 7 HELIX 15 15 LEU A 291 LEU A 292 5 2 HELIX 16 16 ARG A 293 MSE A 297 5 5 HELIX 17 17 LYS A 298 HIS A 305 1 8 HELIX 18 18 GLU A 309 ASN A 314 1 6 HELIX 19 19 ASN A 315 ARG A 332 1 18 HELIX 20 20 SER B 75 GLN B 90 1 16 HELIX 21 21 HIS B 111 THR B 119 1 9 HELIX 22 22 PHE B 122 LEU B 126 5 5 HELIX 23 23 GLU B 150 GLY B 164 1 15 HELIX 24 24 SER B 172 PHE B 183 1 12 HELIX 25 25 LEU B 185 LEU B 200 1 16 HELIX 26 26 ASN B 204 TYR B 215 1 12 HELIX 27 27 LEU B 217 ASN B 231 1 15 HELIX 28 28 ASN B 231 ILE B 236 1 6 HELIX 29 29 GLU B 240 LEU B 244 5 5 HELIX 30 30 PRO B 245 SER B 254 1 10 HELIX 31 31 SER B 262 ARG B 276 1 15 HELIX 32 32 ASN B 277 GLU B 282 1 6 HELIX 33 33 TYR B 284 LYS B 290 1 7 HELIX 34 34 LEU B 291 LEU B 292 5 2 HELIX 35 35 ARG B 293 MSE B 297 5 5 HELIX 36 36 LYS B 298 HIS B 305 1 8 HELIX 37 37 GLU B 309 ASN B 314 1 6 HELIX 38 38 ASN B 315 ARG B 332 1 18
SHEET 1 A 2 ALA A 68 GLU A 72 0 SHEET 2 A 2 ARG B 165 SER B 169 -1 O ILE B 166 N PHE A 71 SHEET 1 B 3 GLU A 107 ALA A 110 0 SHEET 2 B 3 ILE A 96 CYS A 99 -1 N LEU A 98 O PHE A 108 SHEET 3 B 3 ARG A 137 GLU A 139 1 O VAL A 138 N THR A 97 SHEET 1 C 2 ARG A 165 SER A 169 0 SHEET 2 C 2 ALA B 68 GLU B 72 -1 O PHE B 71 N ILE A 166 SHEET 1 D 3 GLU B 107 ALA B 110 0 SHEET 2 D 3 ILE B 96 CYS B 99 -1 N LEU B 98 O PHE B 108 SHEET 3 D 3 ARG B 137 GLU B 139 1 O VAL B 138 N CYS B 99
LINK C SER A -1 N MSE A 0 1555 1555 1.33 LINK C MSE A 0 N GLU A 67 1555 1555 1.34 LINK C GLU A 139 N MSE A 140 1555 1555 1.33 LINK C MSE A 140 N ARG A 141 1555 1555 1.33 LINK C TYR A 160 N MSE A 161 1555 1555 1.34 LINK C MSE A 161 N TYR A 162 1555 1555 1.33 LINK C HIS A 213 N MSE A 214 1555 1555 1.32 LINK C MSE A 214 N TYR A 215 1555 1555 1.33 LINK C ASP A 226 N MSE A 227 1555 1555 1.32 LINK C MSE A 227 N ILE A 228 1555 1555 1.33 LINK C GLN A 296 N MSE A 297 1555 1555 1.33 LINK C MSE A 297 N LYS A 298 1555 1555 1.33 LINK C SER B -1 N MSE B 0 1555 1555 1.33 LINK C MSE B 0 N GLU B 67 1555 1555 1.32 LINK C GLU B 139 N MSE B 140 1555 1555 1.33 LINK C MSE B 140 N ARG B 141 1555 1555 1.33 LINK C TYR B 160 N MSE B 161 1555 1555 1.34 LINK C MSE B 161 N TYR B 162 1555 1555 1.34 LINK C HIS B 213 N MSE B 214 1555 1555 1.33 LINK C MSE B 214 N TYR B 215 1555 1555 1.33 LINK C ASP B 226 N MSE B 227 1555 1555 1.33 LINK C MSE B 227 N ILE B 228 1555 1555 1.33 LINK C GLN B 296 N MSE B 297 1555 1555 1.33 LINK C MSE B 297 N LYS B 298 1555 1555 1.33
SITE 1 AC1 5 ASP A 95 ARG A 112 SER A 113 ASP B 95 SITE 2 AC1 5 SER B 113 SITE 1 AC2 1 THR B 170
CRYST1 41.093 68.879 136.834 90.00 97.44 90.00 P 1 21 1 4
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.024335 0.000000 0.003178 0.00000
SCALE2 0.000000 0.014518 0.000000 0.00000
SCALE3 0.000000 0.000000 0.007370 0.00000